LLYZ uses swap agreements and short-dated listed call options to make bearish bets on the share price of Eli Lilly and Company (NASDAQ: LLY). LLY is a global pharmaceutical company that engages in the discovery, development, manufacture, and marketing of innovative medicines in various therapeutic areas, including neuroscience, endocrinology, oncology, cardiovascular diseases, and immunology. LLYs portfolio covers a wide range of prescription drugs, biologics, and animal health products. The fund seeks to maintain daily inverse leveraged exposure equivalent to 200% of the daily percentage change in LLY price through daily rebalancing. Returns may deviate from the expected -2x if held for longer than a single day due to factors such as volatility and compounding effects. The fund expects to invest in US Government securities, money market funds, short-term bond ETFs, and corporate debt as collateral.
公司网站 :
https://www.defianceetfs.com/llyz/
总经理:-
建立时间:2025
公司总部:Defiance Daily Target 2X Short LLY ETF
领域:Miscellaneous
行业:Investment trusts/Mutual funds